A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Sasanlimab
Related studies linked through entity extraction aliases.
A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
A Clinical Trial of PF-08046037 Alone or With Sasanlimab in Patients With Advanced or Metastatic Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With Cancer
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines.
- Status
- TERMINATED
- Phase
- PHASE1
A Study in Advanced/Metastatic Solid Tumors With the Study Medicine (PF-07329640) When Given Alone or In Combination
- Status
- TERMINATED
- Phase
- PHASE1
A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Immuno-pet IMaging ResPonses AdministeRed Immune CheckpoiNt InhibiTor
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
PF-07225570 Alone or in Combination With an Anti-PD-1 Antibody in Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)
- Status
- WITHDRAWN
- Phase
- PHASE1
Neoadjuvant Sasanlimab With Radiation as an in Situ Vaccine for Cisplatin-ineligible Muscle Invasive Bladder Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Study of PF-07263689 in Participants With Selected Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Study of Immunotherapy (Sasanlimab) in Combination With Targeted Therapies in People With Advanced Non-small Cell Lung Cancer (NSCLC) (Landscape 1011 Study)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of PF-07265807 in Participants With Metastatic Solid Tumors.
- Status
- TERMINATED
- Phase
- PHASE1
A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer
- Status
- TERMINATED
- Phase
- PHASE1